Literature DB >> 22643730

Recent progress in henipavirus research: molecular biology, genetic diversity, animal models.

Barry Rockx1, Richard Winegar, Alexander N Freiberg.   

Abstract

Nipah and Hendra virus are members of a newly identified genus of emerging paramyxoviruses, the henipaviruses. Both viruses have the ability to cause severe pulmonary infection and severe acute encephalitis. Following their discovery in the 1990s, outbreaks caused by these zoonotic paramyxoviruses have been associated with high public health and especially economic threat potential. Currently, only geographic groupings in Asia and Australia have been described for the henipaviruses. However, while few viral isolates are available and more detailed characterization is necessary, there has been recent evidence that divergent henipaviruses might be present on the African continent. This review endeavours to capture recent advances in the field of henipavirus research, with a focus on genome structure and replication mechanisms, reservoir hosts, genetic diversity, pathogenesis and animal models.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22643730     DOI: 10.1016/j.antiviral.2012.05.008

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  24 in total

1.  A novel factor I activity in Nipah virus inhibits human complement pathways through cleavage of C3b.

Authors:  John B Johnson; Viktoriya Borisevich; Barry Rockx; Griffith D Parks
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

2.  Exploring the Human-Nipah Virus Protein-Protein Interactome.

Authors:  Luis Martinez-Gil; Natalia M Vera-Velasco; Ismael Mingarro
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

3.  Nipah virus entry and egress from polarized epithelial cells.

Authors:  Boris Lamp; Erik Dietzel; Larissa Kolesnikova; Lucie Sauerhering; Stephanie Erbar; Hana Weingartl; Andrea Maisner
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

4.  Characterization of Nipah virus infection in a model of human airway epithelial cells cultured at an air-liquid interface.

Authors:  Olivier Escaffre; Viktoriya Borisevich; Leoncio A Vergara; Julie W Wen; Dan Long; Barry Rockx
Journal:  J Gen Virol       Date:  2016-03-01       Impact factor: 3.891

5.  Nipah Virus C and W Proteins Contribute to Respiratory Disease in Ferrets.

Authors:  Benjamin A Satterfield; Robert W Cross; Karla A Fenton; Viktoriya Borisevich; Krystle N Agans; Daniel J Deer; Jessica Graber; Christopher F Basler; Thomas W Geisbert; Chad E Mire
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

6.  Henipavirus pathogenesis in human respiratory epithelial cells.

Authors:  Olivier Escaffre; Viktoriya Borisevich; J Russ Carmical; Deborah Prusak; Joseph Prescott; Heinz Feldmann; Barry Rockx
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

7.  The immunomodulating V and W proteins of Nipah virus determine disease course.

Authors:  Benjamin A Satterfield; Robert W Cross; Karla A Fenton; Krystle N Agans; Christopher F Basler; Thomas W Geisbert; Chad E Mire
Journal:  Nat Commun       Date:  2015-06-24       Impact factor: 14.919

Review 8.  Animal models for highly pathogenic emerging viruses.

Authors:  David Safronetz; Thomas W Geisbert; Heinz Feldmann
Journal:  Curr Opin Virol       Date:  2013-02-09       Impact factor: 7.090

9.  Atomic resolution description of the interaction between the nucleoprotein and phosphoprotein of Hendra virus.

Authors:  Guillaume Communie; Johnny Habchi; Filip Yabukarski; David Blocquel; Robert Schneider; Nicolas Tarbouriech; Nicolas Papageorgiou; Rob W H Ruigrok; Marc Jamin; Malene Ringkjøbing Jensen; Sonia Longhi; Martin Blackledge
Journal:  PLoS Pathog       Date:  2013-09-26       Impact factor: 6.823

10.  A human lung xenograft mouse model of Nipah virus infection.

Authors:  Gustavo Valbuena; Hailey Halliday; Viktoriya Borisevich; Yenny Goez; Barry Rockx
Journal:  PLoS Pathog       Date:  2014-04-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.